In animal studies, Wang et al. [26] reported that ASTX could inhibit homocysteine-induced endothelial dysfunction by suppressing the homocysteine-induced activation of the VEGF–VEGFR2–FAK signaling axis in vitro. This evidence concerns the gene VEGFA and endothelial dysfunction.